by Talking Medicines | May 25, 2021
We continue to contribute toward the scientific validation of analysing social media to listen to the Voice of the Patient. We are advancing knowledge in this field through AI. Read a summary of the publication below put together by Talking Medicines. Background...
by Talking Medicines | May 24, 2021
From starting life as a thinking-out-loud remark, Talking Medicines has become an international social intelligence provider to global drugs companies, with its unique AI-backed insight into patient experiences of their medicines proving invaluable to the pharma...
by Talking Medicines | Apr 14, 2021
Data insights firm Talking Medicines, specialist in ‘social intelligence’ for the pharmaceutical industry, has appointed Donna Lawson to the position of Head of Data Quality. A particularly good fit for the role, Donna brings with her over two decades’ experience...
by Talking Medicines | Mar 3, 2021
Pharma Business International spoke with Jo Halliday, CEO of Talking Medicines, the world’s first social intelligence company designed specifically for the pharmaceutical industry. The full article can be found here on page 10-11 Tell us about Talking Medicines?...
by Talking Medicines | Feb 4, 2021
Talking Medicines is the world’s first social intelligence company designed specifically for the pharmaceutical industry: PatientMetrx By structuring and translating the patient’s voice on social media into actionable intelligence, it focuses on assisting...
by Talking Medicines | Jan 22, 2021
In December Talking Medicines carried out two ‘pulse’ surveys of the UK public to gauge opinion towards COVID-19 vaccines and found that over the month, attitude had softened, with more people intending to take the vaccine once it becomes available to them. The...
